ALPK1
Basic information
Region (hg38): 4:112285509-112442621
Links
Phenotypes
GenCC
Source:
- retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (Strong), mode of inheritance: AD
- retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (Supportive), mode of inheritance: AD
- retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome | AD | Gastrointestinal | The condition can include splenomegaly and related sequelae, such as cytopenia, and splenectomy has been described as being indicated in some individuals | Gastrointestinal; Hematologic; Neurologic; Ophthalmologic | 22307799; 30967659; 31939038 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
- Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome (1 variants)
- ALPK1-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALPK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 109 | 21 | 132 | |||
missense | 284 | 32 | 36 | 353 | ||
nonsense | 10 | |||||
start loss | 0 | |||||
frameshift | 20 | 25 | ||||
inframe indel | 6 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 16 | 11 | 6 | 33 | ||
non coding | 38 | 43 | ||||
Total | 1 | 0 | 324 | 185 | 62 |
Variants in ALPK1
This is a list of pathogenic ClinVar variants found in the ALPK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-112377800-C-A | Uncertain significance (Sep 26, 2022) | |||
4-112377809-T-C | Inborn genetic diseases • ALPK1-related disorder | Uncertain significance (Aug 19, 2023) | ||
4-112377817-T-C | Uncertain significance (Dec 13, 2022) | |||
4-112377831-G-A | ALPK1-related disorder | Benign (Aug 30, 2023) | ||
4-112377832-G-A | Inborn genetic diseases • ALPK1-related disorder | Uncertain significance (Dec 01, 2023) | ||
4-112377845-T-G | Uncertain significance (Dec 26, 2022) | |||
4-112377846-G-A | Likely benign (Apr 14, 2023) | |||
4-112377850-G-A | Uncertain significance (Aug 17, 2022) | |||
4-112377851-C-G | Uncertain significance (Oct 03, 2023) | |||
4-112377851-C-T | Uncertain significance (Oct 20, 2023) | |||
4-112377852-G-A | Benign (Jan 29, 2024) | |||
4-112377861-G-A | Likely benign (Nov 13, 2023) | |||
4-112377863-C-T | Benign (Aug 17, 2023) | |||
4-112377864-G-A | Likely benign (Jun 11, 2023) | |||
4-112377864-G-C | Likely benign (Feb 15, 2023) | |||
4-112377869-A-C | Uncertain significance (Aug 05, 2022) | |||
4-112377876-G-T | Uncertain significance (Jan 10, 2023) | |||
4-112377879-C-T | Likely benign (Apr 07, 2022) | |||
4-112377880-G-A | Likely benign (Oct 13, 2023) | |||
4-112377890-G-A | Uncertain significance (Dec 30, 2023) | |||
4-112377914-G-A | Likely benign (Nov 28, 2022) | |||
4-112377918-C-T | Likely benign (Sep 28, 2023) | |||
4-112382381-A-G | Likely benign (Mar 10, 2023) | |||
4-112382382-A-G | Likely benign (Apr 09, 2022) | |||
4-112382406-C-A | Uncertain significance (Dec 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALPK1 | protein_coding | protein_coding | ENST00000458497 | 14 | 157112 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.02e-19 | 0.586 | 125039 | 3 | 706 | 125748 | 0.00282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.282 | 680 | 660 | 1.03 | 0.0000345 | 8162 |
Missense in Polyphen | 188 | 192.66 | 0.9758 | 2431 | ||
Synonymous | 0.467 | 254 | 264 | 0.963 | 0.0000156 | 2369 |
Loss of Function | 1.98 | 38 | 53.6 | 0.709 | 0.00000258 | 656 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0109 | 0.0110 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.0136 | 0.0134 |
Finnish | 0.00116 | 0.00116 |
European (Non-Finnish) | 0.00129 | 0.00127 |
Middle Eastern | 0.0136 | 0.0134 |
South Asian | 0.00233 | 0.00232 |
Other | 0.00213 | 0.00212 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine-protein kinase that detects bacterial pathogen-associated molecular pattern metabolites (PAMPs) and initiates an innate immune response, a critical step for pathogen elimination and engagement of adaptive immunity (PubMed:28877472, PubMed:28222186, PubMed:30111836). Specifically recognizes and binds ADP-D-glycero-beta-D-manno-heptose (ADP-Heptose), a potent PAMP present in all Gram-negative and some Gram-positive bacteria (PubMed:30111836). ADP-Heptose-binding stimulates its kinase activity to phosphorylate and activate TIFA, triggering proinflammatory NF-kappa-B signaling (PubMed:30111836). May be involved in monosodium urate monohydrate (MSU)-induced inflammation by mediating phosphorylation of unconventional myosin MYO9A (PubMed:27169898). May also play a role in apical protein transport by mediating phosphorylation of unconventional myosin MYO1A (PubMed:15883161). {ECO:0000269|PubMed:15883161, ECO:0000269|PubMed:27169898, ECO:0000269|PubMed:28222186, ECO:0000269|PubMed:28877472, ECO:0000269|PubMed:30111836}.;
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- loftool
- 0.955
- rvis_EVS
- 1.46
- rvis_percentile_EVS
- 95.18
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- N
- hipred_score
- 0.233
- ghis
- 0.461
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.505
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Alpk1
- Phenotype
Gene ontology
- Biological process
- cytoplasmic pattern recognition receptor signaling pathway;protein phosphorylation;positive regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response
- Cellular component
- cytosol
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;monosaccharide binding